137 related articles for article (PubMed ID: 37259680)
1. Glutamate dehydrogenase combined with ferrochelatase as a biomarker of liver injury induced by antituberculosis drugs.
He B; Cheng X; Xiang HR; Li Y; Zhang QZ; Peng WX; Yang B
Br J Clin Pharmacol; 2023 Oct; 89(10):3092-3104. PubMed ID: 37259680
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of IL-6/IL-10/GLDH may be early recognition markers of anti-tuberculosis drugs (ATB) -induced liver injury.
Xiang HR; Li Y; Cheng X; He B; Li HM; Zhang QZ; Wang B; Peng WX
Toxicol Appl Pharmacol; 2023 Sep; 475():116635. PubMed ID: 37487937
[TBL] [Abstract][Full Text] [Related]
3. The role of the genetic variant FECH rs11660001 in the occurrence of anti-tuberculosis drug-induced liver injury.
Zhang M; Zhu J; Wang N; Liu W; Lu L; Pan H; He X; Yi H; Tang S
J Clin Pharm Ther; 2022 Aug; 47(8):1276-1283. PubMed ID: 35470464
[TBL] [Abstract][Full Text] [Related]
4. Serum biomarkers of isoniazid-induced liver injury: Aminotransferases are insufficient, and OPN, L-FABP and HMGB1 can be promising novel biomarkers.
Cheng X; Zhu JL; Li Y; Luo WW; Xiang HR; Zhang QZ; Peng WX
J Appl Toxicol; 2022 Mar; 42(3):516-528. PubMed ID: 34494278
[TBL] [Abstract][Full Text] [Related]
5. A longitudinal assessment of miR-122 and GLDH as biomarkers of drug-induced liver injury in the rat.
Thulin P; Hornby RJ; Auli M; Nordahl G; Antoine DJ; Starkey Lewis P; Goldring CE; Park BK; Prats N; Glinghammar B; Schuppe-Koistinen I
Biomarkers; 2017 Jul; 22(5):461-469. PubMed ID: 27978773
[TBL] [Abstract][Full Text] [Related]
6. Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments.
Schomaker S; Potter D; Warner R; Larkindale J; King N; Porter AC; Owens J; Tomlinson L; Sauer JM; Johnson K; Aubrecht J
PLoS One; 2020; 15(5):e0229753. PubMed ID: 32407333
[TBL] [Abstract][Full Text] [Related]
7. Involvement of protoporphyrin IX accumulation in the pathogenesis of isoniazid/rifampicin-induced liver injury: the prevention of curcumin.
He L; Guo Y; Deng Y; Li C; Zuo C; Peng W
Xenobiotica; 2017 Feb; 47(2):154-163. PubMed ID: 28118809
[TBL] [Abstract][Full Text] [Related]
8. Assessment of emerging biomarkers of liver injury in human subjects.
Schomaker S; Warner R; Bock J; Johnson K; Potter D; Van Winkle J; Aubrecht J
Toxicol Sci; 2013 Apr; 132(2):276-83. PubMed ID: 23339181
[TBL] [Abstract][Full Text] [Related]
9. Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort.
Church RJ; Kullak-Ublick GA; Aubrecht J; Bonkovsky HL; Chalasani N; Fontana RJ; Goepfert JC; Hackman F; King NMP; Kirby S; Kirby P; Marcinak J; Ormarsdottir S; Schomaker SJ; Schuppe-Koistinen I; Wolenski F; Arber N; Merz M; Sauer JM; Andrade RJ; van Bömmel F; Poynard T; Watkins PB
Hepatology; 2019 Feb; 69(2):760-773. PubMed ID: 29357190
[TBL] [Abstract][Full Text] [Related]
10. Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients.
Chan SL; Chua APG; Aminkeng F; Chee CBE; Jin S; Loh M; Gan SH; Wang YT; Brunham LR
PLoS One; 2017; 12(10):e0186200. PubMed ID: 29036176
[TBL] [Abstract][Full Text] [Related]
11. Advantages of glutamate dehydrogenase as a blood biomarker of acute hepatic injury in rats.
O'Brien PJ; Slaughter MR; Polley SR; Kramer K
Lab Anim; 2002 Jul; 36(3):313-21. PubMed ID: 12144742
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of NAT2, CYP2E1, GST, and HLA related to drug-induced liver injury in indonesian tuberculosis patients.
Perwitasari DA; Darmawan E; Mulyani UA; Vlies PV; Alffenaar JC; Atthobar J; Wilffert B
Int J Mycobacteriol; 2018; 7(4):380-386. PubMed ID: 30531039
[TBL] [Abstract][Full Text] [Related]
13.
Jaramillo-Valverde L; Levano KS; Tarazona DD; Vasquez-Dominguez A; Toledo-Nauto A; Capristano S; Sanchez C; Tarazona-Santos E; Ugarte-Gil C; Guio H
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232322
[TBL] [Abstract][Full Text] [Related]
14. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the Sensitivity and Specificity of Promising Circulating Biomarkers to Diagnose Liver Injury in Humans.
Llewellyn HP; Vaidya VS; Wang Z; Peng Q; Hyde C; Potter D; Wang J; Zong Q; Arat S; Martin M; Masek-Hammerman K; Warner R; Johnson K; Kullak-Ublick GA; Aithal GP; Dear JW; Ramaiah SK
Toxicol Sci; 2021 Apr; 181(1):23-34. PubMed ID: 33483742
[TBL] [Abstract][Full Text] [Related]
16. Glutamate dehydrogenase as a biomarker for mitotoxicity; insights from furosemide hepatotoxicity in the mouse.
Church RJ; Schomaker SJ; Eaddy JS; Boucher GG; Kreeger JM; Aubrecht J; Watkins PB
PLoS One; 2020; 15(10):e0240562. PubMed ID: 33035276
[TBL] [Abstract][Full Text] [Related]
17. Urine metabolomics and microbiome analyses reveal the mechanism of anti-tuberculosis drug-induced liver injury, as assessed for causality using the updated RUCAM: A prospective study.
Wang MG; Wu SQ; Zhang MM; He JQ
Front Immunol; 2022; 13():1002126. PubMed ID: 36483548
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients.
Teixeira RL; Morato RG; Cabello PH; Muniz LM; Moreira Ada S; Kritski AL; Mello FC; Suffys PN; Miranda AB; Santos AR
Mem Inst Oswaldo Cruz; 2011 Sep; 106(6):716-24. PubMed ID: 22012226
[TBL] [Abstract][Full Text] [Related]
19. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study.
Wondwossen Abera ; Waqtola Cheneke ; Gemeda Abebe
Int J Mycobacteriol; 2016 Mar; 5(1):14-20. PubMed ID: 26927985
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.
Ben Mahmoud L; Ghozzi H; Kamoun A; Hakim A; Hachicha H; Hammami S; Sahnoun Z; Zalila N; Makni H; Zeghal K
Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
